Abstract
Emerging trends of antimicrobial resistance and development of multidrug resistance and pan resistant strains have become a significant public health problem worldwide. The rate at which newer drugs are developing has slowed down and clinicians are left with only limited therapeutic options for treatment of the patient. We are heading towards the pre antibiotic discovery phase where mortality was high due to unavailability of appropriate drugs; however, in current situation due to misuse or over use of antibiotics, microbes have developed newer methods of resistance, thus rendering these antimicrobials ineffective in their action which has resulted in increased morbidity and mortality among patient and increase in the health care expenditure. Antimicrobial resistance continues to be a major public health problem of international concern. As there is alarming situation globally due to development of multi and pan resistant bacteria which are also known as superbugs, these superbugs have resulted in havoc as these infections are not treatable and is of great concern to the treating physician. Judicious use of antibiotics and implementation of antibiotic stewardship program are the only ways to combat the current situation. The present review aims to provide information on framing of antibiotic policy and implementation of antimicrobial stewardship program.
Full text article
References
Ashiru-Oredope, D., Sharland, M., Charani, E., McNulty, C., Cooke, J. 2012. Improving the quality of antibiotic prescribing in the NHS by developing a new Antimicrobial Stewardship Programme: Start Smart–Then Focus. Journal of Antimicrobial Chemotherapy, 67(Suppl 1): i51–i63.
Avdic, E., Cushinotto, L. A., Hughes, A. H., Hansen, A. R., Efird, L. E., Bartlett, J. G., Cosgrove, S. E. 2012. Impact of an Antimicrobial Stewardship Intervention on Shortening the Duration of Therapy for Community-Acquired Pneumonia. Clinical Infectious Diseases, 54(11):1581–1587.
Baggs, J., Fridkin, S. K., Pollack, L. A., Srinivasan, A., Jernigan, J. A. 2006. Estimating National Trends in Inpatient Antibiotic Use Among US Hospitals From. JAMA Internal Medicine, 176(11):1639– 1648.
Centers for Disease Control and Prevention 2020. Current HAI Progress Report 2019: National and State Healthcare-Associated Infections Progress Report. Last Reviewed: October 26, 2021.
Centers for Disease Control and Prevention 2021. Core Elements of Hospital Antibiotic Stewardship Programs. Last Reviewed: April 28, 2021.
CLSI 2020. M-100: Performance Standards for Antimicrobial Susceptibility Testing. Clinical and laboratory Standard Institute, Edition 30th, Standards M02, M07 and M11. ISBN: 9781684400676.
Dalen, D. M., Zvonar, R. K., Jessamine, P. G. 2005. An Evaluation of the Management of Asymptomatic Catheter-Associated Bacteriuria and Candiduria at The Ottawa Hospital. Canadian Journal of Infectious Diseases and Medical Microbiology, 16(3):166–170.
Elligsen, M., Walker, S. A. N., Pinto, R., Simor, A., Mubareka, S., Rachlis, A., Vanessa Allen, Daneman, N. 2012. Audit and Feedback to Reduce Broad-Spectrum Antibiotic Use among Intensive Care Unit Patients a Controlled Interrupted Time Series Analysis. Infection Control & Hospital Epidemiology, 33(4):354–361.
Fishman, N. 2006. Antimicrobial Stewardship. The American Journal of Medicine, 119(6): S53–S61.
Fleming-Dutra, K. E., Hersh, A. L., Shapiro, D. J., Bartoces, M., Enns, E. A., File, T. M., Hicks, L. A. 2010. Prevalence of inappropriate antibiotic prescriptions among US ambulatory care visits. Jama, 315(17):1864–1873.
Fridkin, S., Baggs, J., Fagan, R., Magill, S., Pollack, A., Malpiedi, P., Slayton, R., Khader, K., Rubin, A., Jones, M., Samore, M. H., Dumyati, G., Dodds- Ashley, E., Meek, J., Yousey-Hindes, K., Jernigan, J., Shehab, N., Herrera, R., Mcdonald, C. L. 2014. Vital signs: improving antibiotic use among hospitalized patients. MMWR. Morbidity and Mortality Weekly Report, 63(9):194–200.
Hecker, M. T., Aron, D. C., Patel, N. P., Lehmann, M. K., Donskey, C. J. 2003. Unnecessary Use of Antimicrobials in Hospitalized Patients: Current pattern of misuse with an emphasis on antianaerobic spectrum of activity. Archives of Internal Medicine, 163(8):972–978.
Hicks, L. A., Taylor, T. H., Hunkler, R. J. 2010. U.S. Outpatient Antibiotic Prescribing, 2010. New England Journal of Medicine, 368(15):1461–1462.
Magill, S. S., Edwards, J. R., Beldavs, Z. G., Dumyati, G., Janelle, S. J., Kainer, M. A., Fridkin, S. K. 2011. Emerging infections program healthcare- associated infections and antimicrobial use prevalence survey team. Prevalence of antimicrobial use in US acute care hospitals. JAMA, 312(14):1438– 1446.
Meeker, D., Linder, J. A., Fox, C. R., Friedberg, M. W., Persell, S. D., Goldstein, N. J., Knight, T. K., Hay, J. W., Doctor, J. N. 2016. Effect of Behavioral Interventions on Inappropriate Antibiotic Prescribing Among Primary Care Practices. JAMA, 315(6):562–562.
Mousa, S., Caron, W. P. 2010. Prevention strategies for antimicrobial resistance: a systematic review of the literature. Infection and Drug Resistance, 3:25–33.
Pollack, L. A., van Santen, K. L., Weiner, L. M., Dudeck, M. A., Edwards, J. R., Srinivasan, A. 2016. Antibiotic Stewardship Programs in U.S. Acute Care Hospitals: Findings From the 2014 National Healthcare Safety Network Annual Hospital Survey. Clinical Infectious Diseases, 63(4):443–449.
Sastry, A. S., Deepashree, R. 2019. Essentials of Hospital Infection Control textbook. pages 476–519. Chapter-19/Antimicrobial Stewarship, ISBN: 9789352706907.
Shrestha, N. K., Bhaskaran, A., Scalera, N. M., Schmitt, S. K., Rehm, S. J., Gordon, S. M. 2012. Antimicrobial Stewardship at Transition of Care from Hospital to Community. Infection Control & Hospital Epidemiology, 33(4):401–404.
Trautner, B. W., Grigoryan, L., Petersen, N. J., Hysong, S., Cadena, J., Patterson, J. E., Naik, A.D. 2015. Effectiveness of an Antimicrobial Stewardship Approach for Urinary Catheter– Associated Asymptomatic Bacteriuria. JAMA Internal Medicine, 175(7):1120–1127.
Authors
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.